(5-Tert-butyl-1,3,4-oxadiazol-2-YL)methanamine | 944906-78-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: (5-Tert-butyl-1,3,4-oxadiazol-2-YL)methanamine
• CAS: 944906-78-9
• 化学式: C₇H₁₃N₃O
• 分子量: 155.2
• InChiKey: UCPGZQLXAUPIMA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  64.9
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 Desaturase
  申请人：Black Cameron

  公开号：US20090118296A1

  公开（公告）日：2009-05-07

  Heteroaromatic compounds of structural formula (I) are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease; atherosclerosis; lipid disorders; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; and fatty liver disease.

  结构式（I）的杂环芳香化合物是选择性的硬脂酰辅酶A-Δ9-脱饱和酶（SCD1）抑制剂，相对于其他已知的硬脂酰辅酶A脱饱和酶。本发明的化合物对于预防和治疗与异常脂质合成和代谢有关的疾病非常有用，包括心血管疾病、动脉粥样硬化、脂质代谢紊乱、肥胖症、糖尿病、神经系统疾病、代谢综合征、胰岛素抵抗和脂肪肝病。
• IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF
  申请人：BETTA PHARMACEUTICALS CO., LTD

  公开号：US20210040118A1

  公开（公告）日：2021-02-11

  The present invention relates to compounds of Formula I, methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.